Cullinan Therapeutics Overview
Cullinan Therapeutics Discounted Cash Flow
DCF Analysis for CGEM.
Get informed when a big investor buys or sells
+ FollowFair Value
$1.45
Current Fair Value
$1.45
↓ 89.3% Downside
Overvalued by 89.3% based on the discounted cash flow analysis.
Average Upside/Downside (Comparison Companies)
Fair Value vs. Stock Price History
Upside/Downside History
Upside/Downside Comparison